Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy
about
Lentivirus-mediated Gene Transfer in Hematopoietic Stem Cells Is Impaired in SHIV-infected, ART-treated Nonhuman Primates.Outcome of HIV-associated lymphoma in a resource-limited setting of Jos, Nigeria.HIV Infection and Survival Among Women With Cervical Cancer.HIV-associated lymphoma in the era of combination antiretroviral therapy: shifting the immunological landscapeFactors associated with cancer incidence and with all-cause mortality after cancer diagnosis among human immunodeficiency virus-infected persons during the combination antiretroviral therapy era.A comparative study of molecular characteristics of diffuse large B-cell lymphoma from patients with and without human immunodeficiency virus infection.Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy.Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States.Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphomaMeeting the challenge of hematologic malignancies in sub-Saharan AfricaAre cancer outcomes worse in the presence of HIV infection?The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort study.Clinical presentation, treatment, and outcomes among 65 patients with HIV-associated lymphoma treated at the University of North Carolina, 2000-2010Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era.Association of early HIV viremia with mortality after HIV-associated lymphoma.Epstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell Lymphoma.HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons.Burkitt lymphoma in adults.Diagnosis and management of lymphomas and other cancers in HIV-infected patients.Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort.Clinical management of HIV-associated hematologic malignancies.Head and neck diffuse large B cell lymphomas (HN-DLBCL) in human immunodeficiency virus (HIV) positive patients: long-term results in the highly active antiretroviral therapy (HAART) era.Excess Mortality among HIV-Infected Individuals with Cancer in the United States.Novel tumor markers provide improved prediction of survival after diagnosis of human immunodeficiency virus (HIV)-related diffuse large B-cell lymphoma.Infection-related mortality in Hispanic and non-Hispanic children with cancer.HIV-associated lymphoma sub-type distribution, immunophenotypes and survival in an urban clinic population.HIV-1 Tat protein induces DNA damage in human peripheral blood B-lymphocytes via mitochondrial ROS production.Survival Deficit for HIV-Infected Lymphoma Patients in the National Cancer Database.Ten-year survival among HIV-1-infected subjects with AIDS or non-AIDS-defining malignancies
P2860
Q27318042-1C4B1191-A280-4902-8723-F9C4847E2FADQ33767818-2A8A4268-EB02-42AC-9914-4C2CA9A10451Q33816855-1CA6A367-1589-4CAE-9155-B396D2D717B8Q34671009-5A01DFCC-E04C-452C-912E-6C04906EFBDEQ35071910-DC26DEA3-FEF6-4DDB-98EB-28ED080B9827Q35230899-BC73F909-D4D0-47BC-99BE-10580592F22AQ35233148-D0005B4E-4386-4E0B-85DD-514C321C648AQ35847460-405107ED-6682-46FA-B63E-F2400FBCF713Q35848330-830ADA48-400F-4CE1-8C1A-8BD74EF5811AQ35865085-B66F0342-C603-4851-9CAD-C0A89EAEAC7DQ35922867-E3E58DAA-4274-4B7C-912F-619EC5DF17E5Q36034748-EE561C2F-9058-454B-A73B-01EB2FD81DA2Q36102589-E6D78FB4-7F8C-42F7-A50A-7C942341D6B6Q37106782-19AEAE4F-7143-4E28-87B1-31BAC0AD6855Q37171460-B77B2B36-28B0-4E1A-BE66-3F61D496D2E4Q37355725-A93E9474-E82F-4D51-A1B3-4E13DA4B4A7FQ37355991-49DFBD45-267A-49C0-9CC9-FE59F484B649Q37933440-3DDB64FE-9A88-4795-8B05-6DDF121960C3Q38194845-E88ABCB3-A692-4E94-B70E-1DC79CAAA3BEQ38414729-4E33FAD7-191A-4B24-B17C-7D251CACF1B1Q38664912-7ACFB1D9-7788-42FE-90AF-B569B46C1352Q38681596-32B2F6DF-6D71-4C3F-AB83-050559E37FE4Q38723336-65E6DF46-C4A7-44D3-ACCB-624C0A9EAEEEQ38727337-0B141CED-32BE-4C4F-A717-4ABD2BFE5C4EQ40240367-DFC01DE0-AC5C-4B82-85E3-D33DB2F2746CQ40284342-497C6FA8-0542-4928-A046-2A9EEEE3C92FQ46245165-1718F215-A20C-4ED3-B37C-8065785C88CDQ50862381-AD85482D-EBE0-443C-93A7-A786FAC3EECEQ58290740-52E90834-1228-4AED-9739-F2A5625435BB
P2860
Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Survival of non-Hodgkin lympho ...... ombined antiretroviral therapy
@ast
Survival of non-Hodgkin lympho ...... ombined antiretroviral therapy
@en
type
label
Survival of non-Hodgkin lympho ...... ombined antiretroviral therapy
@ast
Survival of non-Hodgkin lympho ...... ombined antiretroviral therapy
@en
prefLabel
Survival of non-Hodgkin lympho ...... ombined antiretroviral therapy
@ast
Survival of non-Hodgkin lympho ...... ombined antiretroviral therapy
@en
P2093
P2860
P1433
P1476
Survival of non-Hodgkin lympho ...... ombined antiretroviral therapy
@en
P2093
Daniel Klein
Donald Abrams
Lanfang Xu
Michael Horberg
Michael Silverberg
Wendy Leyden
William Towner
P2860
P304
P356
10.1097/QAD.0B013E32833A0961
P407
P577
2010-07-01T00:00:00Z